Inhibiting epigenetic enzymes to improve atherogenic macrophage functions.

[1]  M. D. de Winther,et al.  Macrophage polarization: the epigenetic point of view , 2014, Current opinion in lipidology.

[2]  J. Repa,et al.  Histone Deacetylase 9 Represses Cholesterol Efflux and Alternatively Activated Macrophages in Atherosclerosis Development , 2014, Arteriosclerosis, thrombosis, and vascular biology.

[3]  C. Glass,et al.  Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions , 2014, EMBO molecular medicine.

[4]  T. Doi,et al.  Epigallocatechin gallate decreases the micellar solubility of cholesterol via specific interaction with phosphatidylcholine. , 2014, Journal of agricultural and food chemistry.

[5]  M. Daemen,et al.  Atherosclerotic Plaque Destabilization: Mechanisms, Models, and Therapeutic Strategies , 2014, Circulation research.

[6]  K. Moore,et al.  Macrophages in atherosclerosis: a dynamic balance , 2013, Nature Reviews Immunology.

[7]  Reto Asmis,et al.  Bioenergetic Profiles Diverge During Macrophage Polarization: Implications for the Interpretation of 18F-FDG PET Imaging of Atherosclerosis , 2013, The Journal of Nuclear Medicine.

[8]  L. Ivashkiv.  Epigenetic regulation of macrophage polarization and function. , 2013, Trends in immunology.

[9]  Liang Zheng,et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α , 2013, Nature.

[10]  M. Comalada,et al.  Deacetylation of C/EBPβ is required for IL‐4‐induced arginase‐1 expression in murine macrophages , 2012, European journal of immunology.

[11]  Ji-Young Lee,et al.  Unsaturated fatty acids repress expression of ATP binding cassette transporter A1 and G1 in RAW 264.7 macrophages. , 2012, The Journal of nutritional biochemistry.

[12]  R. Xavier,et al.  Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes , 2012, Proceedings of the National Academy of Sciences.

[13]  A. Guo,et al.  MLL1, a H3K4 methyltransferase, regulates the TNF&agr;-stimulated activation of genes downstream of NF-&kgr;B , 2012, Journal of Cell Science.

[14]  A. Sood,et al.  Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer , 2012, Breast Cancer Research.

[15]  Patrick De Baetselier,et al.  Pivotal Advance: Arginase‐1‐independent polyamine production stimulates the expression of IL‐4‐induced alternatively activated macrophage markers while inhibiting LPS‐induced expression of inflammatory genes , 2012, Journal of leukocyte biology.

[16]  M. D. de Winther,et al.  Molecular Pathways Regulating Macrophage Polarization: Implications for Atherosclerosis , 2012, Current Atherosclerosis Reports.

[17]  J. Li,et al.  Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage. , 2012, Free radical biology & medicine.

[18]  A. Mantovani,et al.  Regulation and function of the E-cadherin/catenin complex in cells of the monocyte-macrophage lineage and DCs. , 2012, Blood.

[19]  M. Nilsson,et al.  Activated microglia decrease histone acetylation and Nrf2-inducible anti-oxidant defence in astrocytes: Restoring effects of inhibitors of HDACs, p38 MAPK and GSK3β , 2011, Neurobiology of Disease.

[20]  B. Hong,et al.  Identification of Dehydroxytrichostatin A as a Novel Up-Regulator of the ATP-Binding Cassette Transporter A1 (ABCA1) , 2011, Molecules.

[21]  P. François,et al.  Histone deacetylase inhibitors impair innate immune responses to Toll-like receptor agonists and to infection. , 2011, Blood.

[22]  Michael R. Elliott,et al.  Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2 , 2010, Circulation research.

[23]  K. Schroder,et al.  Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll‐like receptor 4 agonist LPS , 2010, Journal of leukocyte biology.

[24]  H. Pircher,et al.  Alternatively activated macrophages engage in homotypic and heterotypic interactions through IL-4 and polyamine-induced E-cadherin/catenin complexes. , 2009, Blood.

[25]  Xiaoping Chen,et al.  The NF-κB Factor RelB and Histone H3 Lysine Methyltransferase G9a Directly Interact to Generate Epigenetic Silencing in Endotoxin Tolerance* , 2009, The Journal of Biological Chemistry.

[26]  Jae Kwon Lee,et al.  Anti-inflammatory effect of Trichostatin-A on murine bone marrow-derived macrophages , 2009, Archives of pharmacal research.

[27]  Kyung-Chul Choi,et al.  Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. , 2009, Cancer research.

[28]  H. Lehr,et al.  Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice , 2008, Gut.

[29]  D. Greaves,et al.  Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. , 2006, Cell metabolism.

[30]  H. Kwon,et al.  Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[31]  L. Augenlicht,et al.  Requirement of Histone Deacetylase Activity for Signaling by STAT1* , 2004, Journal of Biological Chemistry.

[32]  P. Fu,et al.  Enzymatic determination of total serum cholesterol. , 1974, Clinical chemistry.